Please login to the form below

NTDT

This page shows the latest NTDT news and features for those working in and with pharma, biotech and healthcare.

Novartis' Exjade gets EU approval for thalassaemia

Novartis' Exjade (deferasirox) has received European approval as a treatment for non-transfusion-dependent thalassaemia (NTDT) syndromes, a group of genetic disorders characterised by red blood cell problems and anaemia. ... This approval is a critical

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Senior Medical Writer: Salary TBC

Client Services Director – Medical Education Agency – North West...: Salary TBC

Account Director, Medical Education: Salary TBC

Global Business Development Director – Health Education: excellent commission

Account Director: Competitive Salary Offered

Engagement Expert, Healthcare Brand Communications, London: Excellent package

Account Director – Healthcare Marketing – Berks: Salary TBC

Business Director: Competitive Salary Offered

Home-based Senior Project Manager – Independent Med Ed: Salary TBC

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

Account Director, Healthcare Marketing Agency: Salary TBC

Account Manager / Senior Account Manager: 35, 000-40, 000

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Account Director – Health Policy – Global Agency: Salary TBC

Account Manager / Account Director: Competative

Senior Account Manager: Competitive Salary Offered

Senior Account Director development role to Business Director, H...: Excellent package

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Medical Writer: Salary TBC

Senior Account Manager, Rare Diseases – Medical Communications, ...: Excellent package

Associate Director: £75, 000-90, 000

Subscribe to our email news alerts

PMHub

Add my company

Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

Not another weight-loss ad: Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up: As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?: Healthcare leaders in the European Union should begin preparing for a breakthrough now...